Evaluation of MASLD Fibrosis, FIB-4 and APRI Score in MASLD Combined with T2DM and MACCEs Receiving SGLT2 Inhibitors Treatment

Hua Liu,1,2,* Yang-Min Hao,1,2,* Sheng Jiang,1,2,* Maiheliya Baihetiyaer,1,2 Cheng Li,3 Guo-Yao Sang,4 Zhiming Li,5 Guo-Li Du1,2,6 1State Key Laboratory of Pathogenesis, Prevention, and Treatment of High Incidence Diseases in Central Asia, Urumqi, Xinjiang, People’s Republic of China; 2D...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Liu H, Hao YM, Jiang S, Baihetiyaer M, Li C, Sang GY, Li Z, Du GL
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Dove Medical Press 2024-06-01
Ráidu:	International Journal of General Medicine
Fáttát:	masld type 2 diabetes mellitus sodium-glucose co-transporter-2 inhibitors macces fib-4 index
Liŋkkat:	https://www.dovepress.com/evaluation-of-masld-fibrosis-fib-4-and-apri-score-in-masld-combined-wi-peer-reviewed-fulltext-article-IJGM
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!